TITAN PHARMACEUTICALS INC (TTNP) Stock Cash Flow
NASDAQ:TTNP - Nasdaq - US8883147055 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.89M | -5.57M | -10.21M | -8.78M | -18.24M | |||
| Depreciation Amortization | 8.00K | 112.00K | 196.00K | 221.00K | 292.00K | |||
| Change In Working Capital | 211.00K | -916.00K | 378.00K | -219.00K | 1.02M | |||
| Interest Paid | 30.00K | 21.00K | N/A | 0.00 | 295.00K | |||
| Other non cash items | 47.00K | -719.00K | 1.45M | 875.00K | -271.00K | |||
| OPERATING CASH FLOW | -5.62M | -7.09M | -8.18M | -7.90M | -17.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -2.00K | 0.00 | -23.00K | -540.00K | |||
| Other Investing Activity | N/A | 734.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 732.00K | 0.00 | -23.00K | -540.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 500.00K | N/A | 0.00 | -946.00K | |||
| Stock Issued/Repurchased | N/A | 9.50M | 4.98M | 8.84M | 18.88M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 10.00M | 4.98M | 8.84M | 17.93M | |||
| CHANGE IN CASH | -4.71M | 3.64M | -3.20M | 919.00K | 190.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.62M | -7.09M | -8.18M | -7.90M | -17.20M | |||
| Capital Expenditure | N/A | -2.00K | 0.00 | -23.00K | -540.00K | |||
| FREE CASH FLOW | -5.62M | -7.09M | -8.18M | -7.92M | -17.74M | |||
All data in USD